Log in

OTCMKTS:THCBFTHC Biomed Intl Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $0.14
50-Day Range
MA: $0.13
52-Week Range
Now: $0.14
Volume25,974 shs
Average Volume57,442 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
THC BioMed International Ltd. engages in the research, development, and cultivation of medical cannabis. It offers horticulture training, record keeping and documenting, research studies, and analytical services. The company was founded on February 2, 1982 and is headquartered in Kelowna, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Other Metals/Minerals
Phone(844) 842-6337



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive THCBF News and Ratings via Email

Sign-up to receive the latest news and ratings for THCBF and its competitors with MarketBeat's FREE daily newsletter.

THC Biomed Intl (OTCMKTS:THCBF) Frequently Asked Questions

How has THC Biomed Intl's stock been impacted by COVID-19 (Coronavirus)?

THC Biomed Intl's stock was trading at $0.0823 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, THCBF shares have increased by 66.5% and is now trading at $0.1370. View which stocks have been most impacted by Coronavirus.

Has THC Biomed Intl been receiving favorable news coverage?

Media coverage about THCBF stock has trended negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. THC Biomed Intl earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the company's share price in the near future. View the latest news about THC Biomed Intl.

Who are some of THC Biomed Intl's key competitors?

Who are THC Biomed Intl's key executives?

THC Biomed Intl's management team includes the following people:
  • John Miller, President, Chief Executive Officer & Director
  • Hee Jung Chun, Chief Financial Officer & Director

What is THC Biomed Intl's stock symbol?

THC Biomed Intl trades on the OTCMKTS under the ticker symbol "THCBF."

How do I buy shares of THC Biomed Intl?

Shares of THCBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is THC Biomed Intl's stock price today?

One share of THCBF stock can currently be purchased for approximately $0.14.

How can I contact THC Biomed Intl?

The company can be reached via phone at (844) 842-6337.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.